[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008466:Mechlorethamine; D008558:Melphalan; D009101:Multiple Myeloma / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010649:Phenylalanine / Q000031:analogs & derivatives; D010950:Plasma Cells; D012509:Sarcoma
D009588:Nitrogen Mustard Compounds; D010649:Phenylalanine; D008466:Mechlorethamine; D008558:Melphalan
HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; MYELOMA, PLASMA CELL/therapy; NITROGEN MUSTARDS/therapeutic use; PHENYLALANINE/related compounds; SARCOMA, RETICULUM CELL/therapy
La DL-p-bis-(2-cloroetil) amino-fenilalanina (sarcolisina) nella chemioterapia antiblastica con particolare riguardo alle emolinfopatie.